Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
DELCATH SYSTEMS Add to My Watchlist (NSDQ: DCTH) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Delcath System 5.00 +0.18 (+3.73%) 681,529
600 Fifth Avenue
23rd Floor
New York, NY 10020 US
(212) 489-2100
(212) 489-2102 fax
www.delcath.com
CEO Eamonn P. Hobbs
Auditor CCR LLP
Exchange Traded NQ
ISIN Number US24661P1049
CIK Number 872912
NAICS Code 325411
Business Summary
A medical technology company that develops and manufactures an innovative device designed to administer high dose chemotherapy and other therapeutic agents directly to diseased organs or regions of the body.
Number of Employees 6
Share Fundamentals
Market Cap 131.58M
Shares Outstanding 26.32M
Float 25.96M
Short Interest 1.93M
Financial Strength
Revenue (TTM) N/A
Earnings (TTM) -$18,867,530
Quick Ratio 0.5:1
Current Ratio 0.6:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs